Neal Koller
Chairman of Directors & Chief Executive Officer Alphyn Biologics
Seminars
Wednesday 4th November 2026
Moving Beyond Single-Target Therapies: Clinical Development Insights from a Multi-Target Platform in Atopic Dermatitis & Molluscum Contagiosum
11:30 am
- Exploring how multi-mechanistic therapeutics may address complex disease biology more effectively than conventional single-target approaches
- Reviewing pharmacokinetic, mechanistic and translational learnings supporting development across inflammatory and infectious dermatological conditions
- Discussing Phase 2 clinical development strategies and crossindication insights to accelerate future applications of multitarget therapeutics
